Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

12-Lipoxygenase Inhibitor Improves Functions of Cytokine-Treated Human Islets and Type 2 Diabetic Islets.

The Journal of clinical endocrinology and metabolism·2017
Same author

Relationship of NADPH Oxidase-1 expression to beta cell dysfunction induced by inflammatory cytokines.

Biochemical and biophysical research communications·2017
Same author

Lipids and immunoinflammatory pathways of beta cell destruction.

Diabetologia·2016
Same author

Interleukin-12 (IL-12)/STAT4 Axis Is an Important Element for β-Cell Dysfunction Induced by Inflammatory Cytokines.

PloS one·2015
Same author

Amelioration of type 1 diabetes following treatment of non-obese diabetic mice with INGAP and lisofylline.

Journal of diabetes mellitus·2015
Same author

Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction.

Diabetologia·2014
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Harnessing the pancreatic stem cell.

David A Taylor-Fishwick1, Gary L Pittenger

  • 1Department of Internal Medicine, Strelitz Diabetes Center, Norfolk, VA 23507, USA. Taylord@evms.edu

Endocrinology and Metabolism Clinics of North America
|November 25, 2010
PubMed
Summary
This summary is machine-generated.

Reprogramming stem cells offers a potential solution for islet transplantation by overcoming donor tissue limitations. This approach leverages the natural adaptability of pancreatic beta-cell mass.

More Related Videos

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells
06:33

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells

Published on: February 2, 2024

Related Experiment Videos

Last Updated: Jun 6, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells
06:33

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells

Published on: February 2, 2024

Area of Science:

  • Developmental biology
  • Stem cell research
  • Endocrinology

Background:

  • Pancreas development involves critical decision points.
  • Islet transplantation faces limitations due to donor tissue scarcity.
  • Beta-cell mass exhibits plasticity in response to physiological changes like pregnancy and obesity.

Purpose of the Study:

  • To explore alternative strategies for pancreatic stem cell generation.
  • To identify potential sources for pancreatic stem cells.
  • To address the limitations of current islet transplantation methods.

Main Methods:

  • Review of existing research on pancreas development.
  • Analysis of stem cell reprogramming techniques.
  • Consideration of beta-cell plasticity mechanisms.

Main Results:

  • Pluripotent stem cell reprogramming presents a viable alternative for generating pancreatic cells.
  • Understanding beta-cell adaptation provides insights into potential therapeutic strategies.
  • Various alternative sources and strategies for pancreatic stem cells are being investigated.

Conclusions:

  • Stem cell reprogramming holds promise for overcoming donor islet shortages.
  • Further research into pancreatic stem cell sources is crucial for regenerative medicine.
  • Harnessing beta-cell plasticity may offer new avenues for diabetes treatment.